# Clinical Trial of Umbilical Cord Mesenchymal Stem Cells in Subacute Ischemic Stroke

> **NCT07197606** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Shanghai IxCell Biotechnology Co., LTD** · enrollment: 86 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Placebo
- **DRUG:** IxCell hUC-MSC-S (Human Umbilical Cord Mesenchymal Stem Cells)

## Key facts

- **NCT ID:** NCT07197606
- **Lead sponsor:** Shanghai IxCell Biotechnology Co., LTD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 86 (ESTIMATED)
- **Last updated:** 2025-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07197606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07197606, "Clinical Trial of Umbilical Cord Mesenchymal Stem Cells in Subacute Ischemic Stroke". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07197606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*